Arterial hypertension (AH) remains one of the most pressing health problems, due to its high prevalence. With effective treatment of hypertension, the risk of cardiovascular complications and mortality are significantly reduced, that is, the main goal of the treatment of hypertension is achieved. European and Ukrainian recommendations for the diagnosis and treatment of hypertension distinguish five main classes of antihypertensive drugs: diuretics, β-blockers, calcium antagonists, angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Based on the foregoing, we can conclude that the third-generation calcium antagonist lercanidipine is a highly effective, longacting antihypertensive drug for the treatment of hypertension of any stage and severity. It has organoprotective properties, is metabolically neutral, is well tolerated and can be successfully used both as monotherapy and in combination with any other (except dihydropyridine calcium antagonists) antihypertensive drugs in both men and women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.